On December 18, 2021, the China Medical Equipment Association successfully held the "2021 Nuclear Medicine Molecular Imaging New Technology Exchange Conference." Due to COVID-19 precautions, the event was hosted online, enhancing the presentation format and content through advanced information technology. Manufacturer representatives reported on new technologies and applications in molecular imaging and interacted with renowned domestic experts online.
At the conference, Novel Medical dispatched Product Manager Ji Yingcai and Senior Algorithm Engineer Gao Lilei to present. They joined industry experts online to discuss the integrated development of nuclear medicine molecular imaging disciplines. Both experts shared their insights in the PET and SPECT sections, detailing Tsinghua University's advanced nuclear detection technology and its applications, earning high praise from industry experts.
In the PET section, Ji Yingcai discussed the self-developed multimodal animal PET/SPECT/CT product, highlighting new technologies and applications. He detailed the product's innovative DOI-PET detection technology, digital ASIC chip technology, precise quantitative reconstruction, and pharmacokinetics. He also explained the research applications, trends, and case studies, showcasing the integration of cutting-edge technology and clinical research.
In the SPECT section, Senior Algorithm Engineer Gao Lilei explained the high-performance MPH multi-pinhole collimator and its application platform. This collimator, leveraging advanced imaging principles and innovative design, significantly improves spatial resolution and detection efficiency. Without rotating the detector, it can complete image acquisition within 5 minutes, providing high-definition, fast imaging for small organs. The company's self-developed NET632 SPECT, known for its superior performance, stability, and maturity, has its specialized functions enhanced and strengthened with the MPH collimator.
Novel Medical upholds the core values of "integrity, responsibility, perseverance, and ownership," aiming to become a leading domestic and internationally renowned medical imaging technology company. Through independent innovation, they strive to provide high-quality products and services, build user confidence in Chinese medical device brands, and support China's health aspirations.
Language
